Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
The PI3K pathway is altered across various cancer types. Here the authors use amplicon exon sequencing to analyze the landscape of somatic mutations affecting the PI3K pathway specifically in breast cancer patients in China.
Guardado en:
Autores principales: | Li Chen, Liu Yang, Ling Yao, Xia-Ying Kuang, Wen-Jia Zuo, Shan Li, Feng Qiao, Yi-Rong Liu, Zhi-Gang Cao, Shu-Ling Zhou, Xiao-Yan Zhou, Wen-Tao Yang, Jin-Xiu Shi, Wei Huang, Xin Hu, Zhi-Ming Shao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/35be9cbfd9d943158a629a540eb68b22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
por: Yujun Hao, et al.
Publicado: (2016) -
Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
por: Ai,Xuejun, et al.
Publicado: (2018) -
Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
por: Inma M. Berenjeno, et al.
Publicado: (2017) -
Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation
por: Ines Martinez-Corral, et al.
Publicado: (2020) -
Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
por: Chang DY, et al.
Publicado: (2021)